DK0445280T3 - Terapeutisk middel og fremgangsmåde til inhibering af vaskularisering af tumorer - Google Patents

Terapeutisk middel og fremgangsmåde til inhibering af vaskularisering af tumorer

Info

Publication number
DK0445280T3
DK0445280T3 DK90914867.8T DK90914867T DK0445280T3 DK 0445280 T3 DK0445280 T3 DK 0445280T3 DK 90914867 T DK90914867 T DK 90914867T DK 0445280 T3 DK0445280 T3 DK 0445280T3
Authority
DK
Denmark
Prior art keywords
tumors
therapeutic agent
inhibiting vascularization
vascularization
inhibiting
Prior art date
Application number
DK90914867.8T
Other languages
English (en)
Inventor
Carl G Hellerqvist
Original Assignee
Univ Vanderbilt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Vanderbilt filed Critical Univ Vanderbilt
Application granted granted Critical
Publication of DK0445280T3 publication Critical patent/DK0445280T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK90914867.8T 1989-09-25 1990-09-13 Terapeutisk middel og fremgangsmåde til inhibering af vaskularisering af tumorer DK0445280T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/411,674 US5010062A (en) 1989-09-25 1989-09-25 Therapeutic agent and method of inhibiting vascularization of tumors

Publications (1)

Publication Number Publication Date
DK0445280T3 true DK0445280T3 (da) 1996-07-08

Family

ID=23629867

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90914867.8T DK0445280T3 (da) 1989-09-25 1990-09-13 Terapeutisk middel og fremgangsmåde til inhibering af vaskularisering af tumorer

Country Status (10)

Country Link
US (1) US5010062A (da)
EP (1) EP0445280B1 (da)
JP (1) JPH0662426B2 (da)
AT (1) ATE136222T1 (da)
AU (1) AU626733B2 (da)
CA (1) CA2042032C (da)
DE (1) DE69026371T2 (da)
DK (1) DK0445280T3 (da)
ES (1) ES2087915T3 (da)
WO (1) WO1991004048A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811403A (en) * 1996-09-30 1998-09-22 Vanderbilt University Polysaccharide toxin from Group B β-hemolytic Streptococcus (GBS) having improved purity
US5858991A (en) * 1997-01-29 1999-01-12 Vanderbilt University Facilitation of wound healing with CM101/GBS toxin
US6028060A (en) * 1997-01-29 2000-02-22 Vanderbilt University Treatment of chronic inflammatory diseases with CM101/GBS toxin
US5981508A (en) 1997-01-29 1999-11-09 Vanderbilt University Facilitation of repair of neural injury with CM101/GBS toxin
US6670337B1 (en) 1998-01-29 2003-12-30 Yeda Reaearch And Development Co., Ltd. Facilitation of wound healing with CM101/GBS toxin
US6756361B1 (en) * 1997-10-14 2004-06-29 Nabi Enterococcus antigens and vaccines
US6803448B1 (en) * 1998-07-22 2004-10-12 Vanderbilt University GBS toxin receptor
US8609614B2 (en) * 1998-07-22 2013-12-17 Vanderbilt University GBS toxin receptor compositions and methods of use
US20040122011A1 (en) * 1998-12-23 2004-06-24 Pharmacia Corporation Method of using a COX-2 inhibitor and a TACE inhibitors as a combination therapy
IL145710A0 (en) * 2000-02-02 2002-07-25 Univ Vanderbilt Methods for preventing or attenuating pathoangiogenic conditions
WO2004062597A2 (en) * 2003-01-09 2004-07-29 The Trustees Of The University Of Pennsylvania Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS557014A (en) * 1978-06-29 1980-01-18 Chugai Pharmaceut Co Ltd Antitumor agent and its preparation
US4522803A (en) * 1983-02-04 1985-06-11 The Liposome Company, Inc. Stable plurilamellar vesicles, their preparation and use
US4882317A (en) * 1984-05-10 1989-11-21 Merck & Co., Inc. Covalently-modified bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers and methods of preparing such polysaccharides and conjugataes and of confirming covalency
NZ222192A (en) * 1986-10-20 1991-03-26 Kanto Ishi Pharma Co Ltd Glycolipid containing n-glycolylneuraminic acid, and preparation thereof
US4939083A (en) * 1986-10-30 1990-07-03 La Jolla Cancer Research Foundation Carbohydrate specific to chronic myelogenous leukemia granulocytes
US4895838A (en) * 1988-03-09 1990-01-23 Trustees Of Boston University Method for provoking angiogenesis by administration of angiogenically active oligosaccharides

Also Published As

Publication number Publication date
ATE136222T1 (de) 1996-04-15
ES2087915T3 (es) 1996-08-01
DE69026371T2 (de) 1996-08-01
WO1991004048A1 (en) 1991-04-04
AU626733B2 (en) 1992-08-06
EP0445280B1 (en) 1996-04-03
JPH0662426B2 (ja) 1994-08-17
DE69026371D1 (de) 1996-05-09
EP0445280A1 (en) 1991-09-11
JPH04501870A (ja) 1992-04-02
AU6513590A (en) 1991-04-18
CA2042032C (en) 1995-10-10
US5010062A (en) 1991-04-23
CA2042032A1 (en) 1991-03-26
EP0445280A4 (en) 1993-05-05

Similar Documents

Publication Publication Date Title
NO20013727D0 (no) Anvendelse av Botulinumtoksin B for fremstilling av et medikament
BR9508245A (pt) Método para inhibir metástase de cáncer por administração oral de pectina citrica modificada solúvel
PT966447E (pt) Moleculas pequenas uteis no tratamento de doencas inflamatorias
DK0445280T3 (da) Terapeutisk middel og fremgangsmåde til inhibering af vaskularisering af tumorer
FI895141A0 (fi) Kelatmedel med orto-ligerande funktionalitet och deras komplexer.
ATE236647T1 (de) Verbesserung der wundheilung mit cm101/gbs-toxin
ATE245991T1 (de) Behandlung chronischer entzündungskrankheiten mit cm101/gbs-toxin
DK0588873T3 (da) Behandling af levercancer
ZA837972B (en) Method of analgesic treatment and pharmaceutical compositions
EP0286802A3 (en) Use of ofloxacin in treating or preventing locally periodontal disease
DK0572549T3 (da) Behandling af ikke-småcellet lungecarcinom
BR9708037A (pt) Método para o tratamento de abuso de substância
ATE167398T1 (de) Behandlungsverfahren für therapiewiderstehende schizophrenie mit amperozide
NO984198D0 (no) Fremgangsmåte for behandling av aggresjon
DE59712247D1 (de) Mammakarzinom-assoziiertes gen
EA199800818A1 (ru) Способ лечения бессонницы
ES2118758T3 (es) Composiciones y metodo para tumores de tejidos blandos.
EA199800820A1 (ru) Способ лечения злоупотребления лекарственными средствами
RU94037731A (ru) Способ лечения рассеянного склероза
RU96122776A (ru) Способ лечения токсических форм дифтерии